Nom du produit:5-Bromo-2-(trifluoromethoxy)aniline

IUPAC Name:5-bromo-2-(trifluoromethoxy)aniline

CAS:886762-08-9
Formule moléculaire:C7H5BrF3NO
Pureté:98%
Numéro de catalogue:CM118425
Poids moléculaire:256.02

Unité d'emballage Stock disponible Prix($) Quantité
CM118425-100g in stock ƴǭ
CM118425-500g in stock ţţř

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:886762-08-9
Formule moléculaire:C7H5BrF3NO
Point de fusion:-
Code SMILES:NC1=CC(Br)=CC=C1OC(F)(F)F
Densité:
Numéro de catalogue:CM118425
Poids moléculaire:256.02
Point d'ébullition:230.2°C at 760 mmHg
N° Mdl:MFCD04039242
Stockage:Keep in dark place, store at 2-8°C.

Column Infos

Onvansertib
Polo-like kinase 1 (PLK1) is a key regulator of the cell-cycle progression found in human cancers, and a potential therapeutic target for oncology drug development. The recent journal Clinical Cancer Research details the Phase 1b Study of Onvansertib in combination with chemotherapy+bevacizumab treatment for patients with patients with KRAS-mutated metastatic colorectal cancer (mCRC).
Cardiff Oncology’s novel inhibitor, Onvansertib effectively targets PLK1, that prevents from tumor cell growth. It aids restore DNA damage and promote the efficacy of the standard of care therapy in a number of indications.

Related Products